M Veje1, P Nolskog2, M Petzold3, T Bergström4, T Lindén5, Y Peker6,7, M Studahl4. 1. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. malin.veje@vgregion.se. 2. Department for Communicable Disease Control in Western Gotaland, Skövde, Sweden. 3. Centre for Applied Biostatistics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 4. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 5. Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 6. Department of Molecular and Clinical Medicine/Cardiology, Sahlgrenska Academy, Gothenburg, Sweden. 7. Department of Pulmonary Medicine, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Abstract
BACKGROUND: Tick-borne encephalitis (TBE), caused by the TBE virus (TBEV), is a major neurotropic infection throughout Europe and Asia, with a considerable risk of neurological sequelae. Our aim was to study the symptoms in patients with TBE in Western Gotaland between 1997 and 2012 in the acute phase and at follow-up after 2-15 years (median: 5.5 years). METHODS: The medical records of 96 patients with TBE were studied. Phone-based interviews were held with 92 patients and 58 controls, matched by age, gender and residential area. The Encephalitis Support Group Questionnaire (ESGQ) 2000 was used, further developed with dimensions and scoring 1-4, where a high score is related to better outcome. Patients and controls also answered a written survey regarding functional outcome of sleep (FOSQ). RESULTS: Of the patients, 35% had a mild disease, 56% moderate and 7.3% severe disease. At the follow-up, patients scored significantly lower than controls in the dimensions of memory/learning, executive functions, vigilance and physical impairments. In addition, the answers concerning tiredness/fatigue, poor concentration/attention, reduced initiative/motivation, balance disturbances, coordination problems, difficulties with short- and long-term memory, learning difficulties and problems with fine motor skills resulted in significantly lower scores in the patients compared with the controls. The patients scored lower than the controls in the FOSQ dimension social outcome. CONCLUSIONS: At the long-term follow-up, the patients scored significantly lower in a diversity of neurocognitive and motor symptoms, in comparison with controls. These sequelae and their pathogenesis should be further explored and specific neurocognitive assessment tests are needed.
BACKGROUND:Tick-borne encephalitis (TBE), caused by the TBE virus (TBEV), is a major neurotropic infection throughout Europe and Asia, with a considerable risk of neurological sequelae. Our aim was to study the symptoms in patients with TBE in Western Gotaland between 1997 and 2012 in the acute phase and at follow-up after 2-15 years (median: 5.5 years). METHODS: The medical records of 96 patients with TBE were studied. Phone-based interviews were held with 92 patients and 58 controls, matched by age, gender and residential area. The Encephalitis Support Group Questionnaire (ESGQ) 2000 was used, further developed with dimensions and scoring 1-4, where a high score is related to better outcome. Patients and controls also answered a written survey regarding functional outcome of sleep (FOSQ). RESULTS: Of the patients, 35% had a mild disease, 56% moderate and 7.3% severe disease. At the follow-up, patients scored significantly lower than controls in the dimensions of memory/learning, executive functions, vigilance and physical impairments. In addition, the answers concerning tiredness/fatigue, poor concentration/attention, reduced initiative/motivation, balance disturbances, coordination problems, difficulties with short- and long-term memory, learning difficulties and problems with fine motor skills resulted in significantly lower scores in the patients compared with the controls. The patients scored lower than the controls in the FOSQ dimension social outcome. CONCLUSIONS: At the long-term follow-up, the patients scored significantly lower in a diversity of neurocognitive and motor symptoms, in comparison with controls. These sequelae and their pathogenesis should be further explored and specific neurocognitive assessment tests are needed.
Authors: Anamaria Ungureanu; Julia van der Meer; Antonela Bicvic; Lena Abbuehl; Gabriele Chiffi; Léonore Jaques; Franziska Suter-Riniker; Stephen L Leib; Claudio L A Bassetti; Anelia Dietmann Journal: BMC Neurol Date: 2021-12-06 Impact factor: 2.474
Authors: Axel Jonasson; Christopher Levin; Marielle Renfors; Sara Strandberg; Birgitta Johansson Journal: Brain Behav Date: 2018-06-29 Impact factor: 2.708
Authors: Karin E Hansson; Anja Rosdahl; Mona Insulander; Sirkka Vene; Lars Lindquist; Sara Gredmark-Russ; Helena H Askling Journal: Clin Infect Dis Date: 2020-01-02 Impact factor: 9.079
Authors: Marion Clé; Patrick Eldin; Laurence Briant; Annie Lannuzel; Yannick Simonin; Philippe Van de Perre; André Cabié; Sara Salinas Journal: J Neuroinflammation Date: 2020-08-10 Impact factor: 8.322
Authors: Benno Kohlmaier; Nina A Schweintzger; Manfred G Sagmeister; Vendula Švendová; Daniela S Kohlfürst; Astrid Sonnleitner; Manuel Leitner; Andrea Berghold; Erich Schmiedberger; Franz Fazekas; Alexander Pichler; Jana Rejc-Marko; Daniel Růžek; Lucie Dufková; Darina Čejková; Petr Husa; Martina Pýchová; Lenka Krbková; Václav Chmelík; Věra Štruncová; Dace Zavadska; Guntis Karelis; Aukse Mickiene; Joanna Zajkowska; Petra Bogovič; Franc Strle; Werner Zenz Journal: Microorganisms Date: 2021-06-30